Based on these differences, we determined that DRD1 and MYCN are the key hub genes nodes of the immune-phenotypic gene expression regulatory network, increasing our understanding of possible HCC mechanisms for improving immunotherapy. Here, DRD1 is linked to hepatocellular carcinoma.